<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to the Regents of the University of Minnesota for $5,998.01 on September 20, 2017. The order, which expired September 30, 2018, carries no set-aside designation and is priced on a firm fixed-price basis. Work is performed in Minneapolis, Minnesota. The contract award number is 17-014806.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Molecular Devices LLC valued at $2,163.00 on March 31, 2016. The order is a firm fixed price modification to de-obligate expired lines. Place of performance is Sunnyvale, California. The ultimate completion date is April 30, 2016.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation on September 15, 2016, for various laboratory supplies with a firm fixed price of $6,684.06. Performance will occur in Grand Island, New York. The order carries an ultimate completion date of September 19, 2017.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $81,885.40 on June 22, 2018, with ultimate completion on December 21, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order was a firm fixed price acquisition for scientific instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio supporting research and diagnostic missions.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for $24,545.41 on August 10, 2016. The order procures various laboratory equipment on a firm fixed price basis. Place of performance is Carlsbad, California. The order is scheduled for completion by September 30, 2016.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Thermo Electron North America LLC for $11,578.02 on May 31, 2019. The order, classified as a firm fixed-price purchase order with no set-aside designation, obligated funds for scientific instrumentation or laboratory equipment support. Work is performed in Bethesda, Maryland. The order's ultimate completion date was June 4, 2020.</p>
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $7,882.56 on March 29, 2016. The order is firm fixed price with no set-aside designation. Place of performance is San Diego, California. The order expired on April 24, 2016. No further details regarding the specific items or services procured are provided in the source material.</p>
The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Siemens Healthcare Diagnostics Inc. valued at $2,967.51 on March 29, 2017, with final completion on April 30, 2017. No set-aside applied. Work is performed in Norwood, Massachusetts. The order was issued on a firm fixed price basis for commercial diagnostic supplies or equipment consistent with the awardee's portfolio of laboratory analyzer consumables and reagents supplied to federal healthcare...
<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Revvity Health Sciences, Inc. for $4,592.16 on November 7, 2014, with completion by November 9, 2015. The order is firm fixed price with no small business set-aside. Work is performed in Shelton, Connecticut. The source does not specify the goods or services procured under this purchase order.</p>
The National Institute of Diabetes and Digestive and Kidney Diseases issued a $74,503 delivery order to Beckman Coulter, Inc. on April 25, 2018, with ultimate completion on April 25, 2019.
The order was issued under a parent Indefinite Delivery Contract with the Office of Logistics and Acquisition Operations for biomedical laboratory equipment, reagents, software, maintenance, and related services. Place of performance is Bethesda, MD. Pricing is firm fixed price with no set-aside applied.